Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 463740, 8 pages
http://dx.doi.org/10.1155/2013/463740
Research Article

Both ERK/MAPK and TGF-Beta/Smad Signaling Pathways Play a Role in the Kidney Fibrosis of Diabetic Mice Accelerated by Blood Glucose Fluctuation

1Department of Endocrinology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
2Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China

Received 9 October 2012; Revised 18 April 2013; Accepted 15 May 2013

Academic Editor: Shahidul Islam

Copyright © 2013 Xiaoyun Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. del Prato, “In search of normoglycaemia in diabetes: controlling postprandial glucose,” International Journal of Obesity, vol. 26, no. 3, pp. S9–S17, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Ceriello, “The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications,” Diabetic Medicine, vol. 15, pp. 188–193, 1998. View at Google Scholar
  3. E. Bonora and M. Muggeo, “Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence,” Diabetologia, vol. 44, no. 12, pp. 2107–2114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Piconi, L. Quagliaro, R. da Ros et al., “Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase,” Journal of Thrombosis and Haemostasis, vol. 2, no. 8, pp. 1453–1459, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Quagliaro, L. Piconi, R. Assaloni, L. Martinelli, E. Motz, and A. Ceriello, “Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation,” Diabetes, vol. 52, no. 11, pp. 2795–2804, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Quagliaro, L. Piconi, R. Assaloni et al., “Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production,” Atherosclerosis, vol. 183, no. 2, pp. 259–267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz, “Diabetic nephropathy: diagnosis, prevention, and treatment,” Diabetes Care, vol. 28, no. 1, pp. 164–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Liu, “Renal fibrosis: new insights into the pathogenesis and therapeutics,” Kidney International, vol. 69, no. 2, pp. 213–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Nishida, Y. Okumura, H. Sato, and K. Hamaoka, “Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy,” Nephrology Dialysis Transplantation, vol. 23, no. 8, pp. 2520–2524, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Wang, V. Koka, and H. Y. Lan, “Transforming growth factor-β and Smad signalling in kidney diseases,” Nephrology, vol. 10, no. 1, pp. 48–56, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Azuma, R. Kawamori, Y. Toyofuku et al., “Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 10, pp. 2275–2280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Piconi, L. Quagliaro, R. Assaloni et al., “Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction,” Diabetes/Metabolism Research and Reviews, vol. 22, no. 3, pp. 198–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Risso, F. Mercuri, L. Quagliaro, G. Damante, and A. Ceriello, “Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture,” American Journal of Physiology—Endocrinology and Metabolism, vol. 281, no. 5, pp. E924–E930, 2001. View at Google Scholar · View at Scopus
  14. L. Monnier, E. Mas, C. Ginet et al., “Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes,” Journal of the American Medical Association, vol. 295, no. 14, pp. 1681–1687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Ye, Z. Tong, Y. Dang et al., “Effects of blood glucose fluctuation on skin biophysical properties, structure and antioxidant status in an animal model,” Clinical and Experimental Dermatology, vol. 35, no. 1, pp. 78–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. González-Avila, C. Iturria, F. Vadillo-Ortega, C. Ovalle, and M. Montaño, “Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model,” Pathobiology, vol. 66, no. 5, pp. 196–204, 1998. View at Google Scholar · View at Scopus
  17. T. S. Polhill, S. Saad, P. Poronnik, G. R. Fulcher, and C. A. Pollock, “Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure,” American Journal of Physiology—Renal Physiology, vol. 287, no. 2, pp. F268–F273, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Stambe, R. C. Atkins, G. H. Tesch, T. Masaki, G. F. Schreiner, and D. J. Nikolic-Paterson, “The role of p38α mitogen-activated protein kinase activation in renal fibrosis,” Journal of the American Society of Nephrology, vol. 15, no. 2, pp. 370–379, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Sugaru, M. Sakai, K. Horigome et al., “SMP-534 inhibits TGF-β-induced ECM production in fibroblast cells and reduces mesangial matrix accumulation in experimental glomerulonephritis,” American Journal of Physiology—Renal Physiology, vol. 289, no. 5, pp. F998–F1004, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Chen, C. Huang, T. A. Morinelli, M. Trojanowska, and R. V. Paul, “Blockade of the effects of TGF-β1 on mesangial cells by overexpression of Smad7,” Journal of the American Society of Nephrology, vol. 13, no. 4, pp. 887–893, 2002. View at Google Scholar · View at Scopus
  21. E. Kalo, Y. Buganim, K. E. Shapira et al., “Mutant p53 attenuates the SMAD-dependent transforming growth factor β1 (TGF-β1) signaling pathway by repressing the expression of TGF-β receptor type II,” Molecular and Cellular Biology, vol. 27, no. 23, pp. 8228–8242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-H. Heldin, K. Miyazono, and P. Ten Dijke, “TGF-β signalling from cell membrane to nucleus through SMAD proteins,” Nature, vol. 390, no. 6659, pp. 465–471, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Ebisawa, M. Fukuchi, G. Murakami et al., “Smurf1 interacts with transforming growth factor-β type I receptor through smad7 and induces receptor degradation,” Journal of Biological Chemistry, vol. 276, no. 16, pp. 12477–12480, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Y. Chen, X. R. Huang, W. Wang et al., “The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential,” Diabetes, vol. 60, no. 2, pp. 590–601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Ka, Y. C. Yeh, X. R. Huang et al., “Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κb (NF-κB) signalling pathways, and improves diabetic nephropathy in mice,” Diabetologia, vol. 55, no. 2, pp. 509–519, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. J. Kattla, R. M. Carew, M. Heljić, C. Godson, and D. P. Brazil, “Protein kinase B/Akt activity is involved in renal TGF-β1-driven epithelial-mesenchymal transition in vitro and in vivo,” American Journal of Physiology—Renal Physiology, vol. 295, no. 1, pp. F215–F225, 2008. View at Publisher · View at Google Scholar · View at Scopus